Feb 27, 2013, 11.21 AM IST | Source: Moneycontrol.com

SMS Pharma hits 52-week high on buyback proposal

Shares of SMS Pharmaceuticals gained nearly 10 percent in early trade to touch a 52-week high of Rs 239.95 on Wednesday after the board of directors approved buy-back proposal worth Rs 46.5 crore (not exceeding 15,50,000 number of shares) at Rs 300 per share yesterday.

Shares of SMS Pharmaceuticals gained nearly 10 percent in early trade to touch a 52-week high of Rs 239.95 on Wednesday after the board of directors approved buy-back proposal worth Rs 46.5 crore (not exceeding 15,50,000 number of shares) at Rs 300 per share yesterday.

The company said the buyback was proposed to be carried out from open market through the Bombay Stock Exchange and the National Stock Exchange.

At 10:49 hours IST, shares rallied 5.51 percent to Rs 230.85 amid hefty volumes on Bombay Stock Exchange., up Rs 12.05, or 5.51%.
 
Market capitalisation of the company currently stands at Rs 231.20 crore.

To see all Budget related News Click Here  

SMS Pharma stock price

On April 23, 2014, SMS Pharmaceuticals closed at Rs 255.00, down Rs 8.95, or 3.39 percent. The 52-week high of the share was Rs 277.80 and the 52-week low was Rs 152.00.


The company's trailing 12-month (TTM) EPS was at Rs 81.00 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 3.15. The latest book value of the company is Rs 286.48 per share. At current value, the price-to-book value of the company is 0.89.

READ MORE ON  SMS Pharmaceuticals, buy-back
Set email alert for

ADS BY GOOGLE

Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Narendra Modi

99374.06 2,015.63 2.07%

1164

Bought today

1291

Sold today

0.97%

User holding

video of the day

Add cyclicals, banks on positive poll outcome: UBS

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.